Ceiba pentandra ethyl acetate extract improves doxorubicin antitumor outcomes against chemically induced liver cancer in rat model: a study supported by UHPLC-Q-TOF-MS/MS identification of the bioactive phytomolecules

Ceiba pentandra ethyl acetate extract improves doxorubicin antitumor outcomes against chemically induced liver cancer in rat model: a study supported by UHPLC-Q-TOF-MS/MS identification of the bioactive phytomolecules

Hepatocellular carcinoma (HCC) is a prevalent cancer worldwide. Late-stage detection, ineffective treatments, and tumor recurrence contribute to the low survival rate of the HCC. Conventional chemotherapeutic drugs, like doxorubicin (DOX), are associated with severe side effects, limited effectivene...

Full description

Bibliographic Details
Main Authors: Mohamed A. A. Orabi, Mohamed E. Abouelela, Faten M. M. Darwish, Mohamed S. A. Abdelkader, Bakheet E. M. Elsadek, Ahmed Abdullah Al Awadh, Mohammed Merae Alshahrani, Abdulaziz Hassan Alhasaniah, Nayef Aldabaan, Reda A. Abdelhamid
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Pharmacology
Subjects:
Ceiba pentandra
antitumor
in vivo
AFP-l3
hepatocellular carcinoma
doxorubicin
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1337910/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1337910/full

Similar Items